1 2 4-triazole compound
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jul 11, 2006
Grant Date -
Jan 6, 2005
app pub date -
Dec 3, 2002
filing date -
Jan 28, 2002
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
A novel 1,2,4-triazole compound which is useful as a therapeutic agent for hyperuricemia and gout due to hyperuricemia is provided. A compound is represented by the following general formula (1): ##STR00001## wherein R.sub.2 represents an unsubstituted or substituted pyridyl group, R.sub.1 represents a similar pyridyl group, a pyridine-N-oxide group corresponding to these pyridyl groups, or a phenyl group, and R.sub.3 represents hydrogen or a lower alkyl group substituted with pivaloyloxy group and R.sub.3 bonds to a nitrogen atom in the ring. A process for production of a compound by reacting a nitrile and a hydrazide, and a therapeutic agent, particularly a xanthine oxidase inhibitor are also provided.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully